21 September 2026
Australia's Telix to buy Germany's ITM Isotope in $1.65 billion deal

Australian biotechnology company Telix Pharmaceuticals has agreed to buy Germany's ITM Isotope in a $1. 65 billion deal, the companies announced on Monday.
About this report
This article contains independently written commentary and community perspective from Downunder Voices.
Join our community
Follow Downunder Voices
Join thousands of readers following news and community stories from Australia, New Zealand and the Pacific.


